Dr Waked is the author of Saliva Cotinine and Exhaled Carbon Monoxide in Real Life Waterpipe Smokers: A Post Hoc Analysis, which was recently published in Tobacco Use Insights.

The Editor in Chief of Tobacco Use Insights recently issued a call for papers

What is the primary focus of your research?

Clinical respiratory diseases, Epidemiology, tobacco.

What are the most exciting developments arising from current research in your area?

We are the first in Lebanon to provide epidemiologic data on COPD and Asthma.

We are the first to publish on Water pipe smoke live data and tocicology data.

Who are your main collaborators? Please describe your work with them.

Dr Pascale Salameh, Epidemiologist of high standard.

Dr Zeina Aoun, chest physician and highly reliable and scientific source.

How did you come to be working in your research area?

I am in a University Hospital in Lebanon. To be promoted you need to have publications and leadership

What do you think about the development of open access publishing? What motivated you to do so?

Easier access with quality

What articles and/or books have you published recently?

• Salameh P, WAKED M, Aoun Z. Narguile smoking: Construction and validation LNDS-17 dependence scale. Nicotine Tobacco Research 2008; 10(1): 149-158.

• WAKED M, Salameh P. Asthma, Allergic Rhinitis and Eczema in 5-12 year old school children across Lebanon. Public Health 2008; 122/9: 965-973. www http://dx.doi.org/10.1016/j.puhe.2007.10.006.

• WAKED M; Salameh P. Risk factors of asthma and allergic diseases in 5-14y old Lebanon School Children. Journal of Asthma and Allergy 2009; 2: 1-7.

• WAKED M, Salameh P, Aoun Z. Water-pipe Smokers in Lebanon: A pilot study. Eastern Mediterranean Health Journal, Journal 2009; 15(2): 432-442.

• Salameh P, Aoun Bacha Z, WAKED M. Saliva Cotinine and Exhaled Carbon Monoxide in Real Life Water pipe Smokers: A post hoc analysis. Tobacco Use Insight, Tobacco Use Insights 2009:2, 1–10.

• A. Taher, P. Salameh, G. Dabar, WAKED M, et al. The AVAIL ME project: a first regional evaluation of venous thromboembolism (VTE) risk and prophylaxis practice. Abstract submitted for the XXII Congress of the International Society on Thrombosis and Haemostasis, taking place in Boston, USA from July 11 to 16, 2009.

• Kreidy R, WAKED M, Stephan E, Jureidini I, Irani-Hakime N. Contribuation of factor VR506Q-Leiden, prothrombin g 20210a and MTHFR C 677T mutation to the genetic susceptibility of deep vein thrombosis of lower extremities. Is screening for factor V H 1299 R and MTHFR A 1298 C justified? International Angiology 2009: 28 supp 1 number 4.

share on